Back to Sites

Rush Univ./Cook County Hosp. Chicago CRS

Site Number

32515

Address

Rush Children's Hospital
Department of Pediatric Infectious Diseases
1725 West Harrison, Suite 718
Chicago, IL 60612
United States of America

IMPAACT Members at this Site

Latania Logan Co-Investigator

Maureen McNichols CRS Coordinator

Mariam Aziz CRS Leader

James McAuley CRS Leader

Isela Alvarez Data Management Staff

Mariam Aziz Principal Investigator

Dorothy Rego Regulatory Coordinator

Judith Senka Research Nurse

Studies at this Site

P1058A: Pharmacokinetics of New Classes of Antiretroviral Drug Combinations

DAIDS Number

10809

Research Area

Other

Study Status

Concluded

P1085: Human Papilloma Virus (HPV) Type-Specific Antibody

DAIDS Number

10826

Research Area

Other

Study Status

Concluded

P1089: Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Chldren/youth

DAIDS Number

11670

Research Area

Other

Study Status

Concluded

P1093: PK, Safety, Tolerability and Antiviral Activity of Dolutegravir

DAIDS Number

11773

Research Area

Therapeutics

Study Status

Participants Off Study and Primary Analysis Completed

P1096: Phase 1 Study of Live Attenuated Recombinant (cp) 45 Human Parainfluenza Type 3 Vaccine

DAIDS Number

11796

Research Area

Vaccine

Study Status

Concluded

P1097: Raltegravir PK Study

DAIDS Number

11790

Research Area

Treatment

Study Status

Concluded

P1110: Safety and PK of RAL in Neonates

DAIDS Number

11891

Research Area

Treatment

Study Status

Concluded

P1114: Safety and Immunogenicity of an RSV Vaccine cps2

DAIDS Number

11948

Research Area

Complications & Comorbidities

Study Status

Concluded

P1115: Very Early Intensive Treatment of Infants Living with HIV to Achieve HIV Remission: A Phase I/II Proof of Concept Study

DAIDS Number

11954

Research Area

Cure and Immunotherapy

Study Status

Enrolling

IMPAACT 2000: A Phase I Study of the Safety and Immunogenicity of Recombinant Live-Attenuated Respiratory Syncytial Virus Vaccine RSV LID delta M2-2 in RSV-Seronegative Infants and Children

DAIDS Number

12016

Research Area

Complications & Comorbidities

Study Status

Concluded